The acquisition of the over-the-counter nicotine replacement therapy transdermal patch was completed last month following issuance of the proposed consent order from the US Federal Trade Commission (FTC).
Velcade covers use of bortezomib along with rituximab, cyclophosphamide, doxorubicin and prednisone for the treatment of adult patients with previously untreated MCL, who are unsuitable for haematopoietic stem
As part of the deal, OncoEthix will receive an upfront payment of up to $110m from Merck. Upon certain clinical and regulatory events being achieved, OncoEthix will also
The BLA was based on results from the LEOPOLD clinical trials, which evaluated BAY 81-8973 in adults and children using two- and three-times-per-week prophylaxis dosing regimens. BAY 81-8973,
The trial met its primary endpoint showing that HZ/su reduced the risk of shingles by 97.2% in adults aged 50 years and older compared to placebo. HZ/su is
Terms of the transaction were not disclosed. The deal is said to strengthen KCR’s presence in Ukraine, making the country an important location for the firm in the
The drug is approved for patients who are in complete response or partial response to platinum-based chemotherapy. Olaparib is a poly ADP-ribose polymerase (PARP) inhibitor that exploits tumor
The company uses its Dynamic Tumor Targeting Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designed to selectively attack tumor cells, reduce toxicity by sparing the body’s
The two products have been approved by Health Canada and are indicated for the treatment of hypertension or high blood pressure. Hypertension occurs when the blood pressure in
The amendment to the Supply Agreement between Alexza and Autoliv, signed on December 11, 2014, updates certain terms of prior agreements between the companies. The Amendment states that
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.